Xspray Pharma AB (publ) (LON:0GHZ)
London
· Delayed Price · Currency is GBP · Price in SEK 40.75
-0.90 (-2.16%)
At close: Dec 30, 2024
Xspray Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 208.24 | 166.3 | 120.17 | 271.88 | 325.6 | Upgrade
|
| Cash & Short-Term Investments | 208.24 | 166.3 | 120.17 | 271.88 | 325.6 | Upgrade
|
| Cash Growth | 25.21% | 38.39% | -55.80% | -16.50% | 55.14% | Upgrade
|
| Other Receivables | 4.02 | 4.17 | 2.59 | 2.5 | 3.32 | Upgrade
|
| Receivables | 4.02 | 4.17 | 2.59 | 2.5 | 3.32 | Upgrade
|
| Inventory | 20.34 | 43.78 | 8.55 | 6.2 | - | Upgrade
|
| Prepaid Expenses | 2.48 | 3.57 | 0.93 | 1.48 | 2.1 | Upgrade
|
| Other Current Assets | 0 | - | -0 | -0 | - | Upgrade
|
| Total Current Assets | 235.07 | 217.82 | 132.23 | 282.07 | 331.02 | Upgrade
|
| Property, Plant & Equipment | 79.18 | 107.65 | 64.6 | 44.6 | 42.67 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Long-Term Deferred Charges | 478.93 | 436.78 | 385.6 | 296.24 | 231.62 | Upgrade
|
| Other Long-Term Assets | 3.17 | 3.02 | 3 | - | - | Upgrade
|
| Total Assets | 796.34 | 765.26 | 585.43 | 622.9 | 605.3 | Upgrade
|
| Accounts Payable | 17.08 | 12.47 | 14.79 | 16.87 | 8.44 | Upgrade
|
| Accrued Expenses | 18.63 | 16.31 | 11.41 | 10.3 | 8.54 | Upgrade
|
| Short-Term Debt | 96 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 5.11 | 4.86 | 1.57 | 2.05 | 1.99 | Upgrade
|
| Other Current Liabilities | 9.31 | 6.26 | 1.09 | 0.75 | 0.86 | Upgrade
|
| Total Current Liabilities | 146.14 | 39.9 | 28.85 | 29.97 | 19.82 | Upgrade
|
| Long-Term Leases | 27.11 | 31.95 | 0.56 | 1.19 | 2.9 | Upgrade
|
| Other Long-Term Liabilities | -0 | - | - | - | - | Upgrade
|
| Total Liabilities | 173.25 | 71.85 | 29.41 | 31.15 | 22.72 | Upgrade
|
| Common Stock | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Additional Paid-In Capital | 1,425 | 1,216 | 907.42 | 813.48 | 709.41 | Upgrade
|
| Retained Earnings | -839.25 | -553.93 | -374.08 | -242.41 | -145.71 | Upgrade
|
| Comprehensive Income & Other | 0 | -0 | - | - | - | Upgrade
|
| Shareholders' Equity | 623.1 | 693.41 | 556.02 | 591.75 | 582.59 | Upgrade
|
| Total Liabilities & Equity | 796.34 | 765.26 | 585.43 | 622.9 | 605.3 | Upgrade
|
| Total Debt | 128.22 | 36.81 | 2.13 | 3.23 | 4.88 | Upgrade
|
| Net Cash (Debt) | 80.02 | 129.5 | 118.04 | 268.65 | 320.72 | Upgrade
|
| Net Cash Growth | -38.21% | 9.70% | -56.06% | -16.23% | 56.80% | Upgrade
|
| Net Cash Per Share | 2.41 | 4.87 | 5.60 | 13.96 | 18.63 | Upgrade
|
| Filing Date Shares Outstanding | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Total Common Shares Outstanding | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Working Capital | 88.93 | 177.91 | 103.38 | 252.1 | 311.2 | Upgrade
|
| Book Value Per Share | 16.78 | 22.19 | 24.52 | 28.61 | 30.84 | Upgrade
|
| Tangible Book Value | 623.1 | 693.41 | 556.02 | 591.75 | 582.59 | Upgrade
|
| Tangible Book Value Per Share | 16.78 | 22.19 | 24.52 | 28.61 | 30.84 | Upgrade
|
| Machinery | - | 50.03 | 49.82 | 46.96 | 39.87 | Upgrade
|
| Construction In Progress | - | 59.37 | 46.57 | 20.04 | 15.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.